tetano
Editor, Senior Moderator
Turk J Anaesthesiol Reanim
. 2021 Dec;49(6):480-483.
doi: 10.5152/TJAR.2020.1135.
Thrombotic Events Related to Extracorporeal Membrane Oxygenation in COVID-19-Associated Severe Acute Respiratory Distress Syndrome
Verda Tuna[SUP] 1 [/SUP], Perihan Ergin Özcan[SUP] 1 [/SUP], Emre Çeliksoy[SUP] 1 [/SUP], Özlem Polat[SUP] 1 [/SUP], İlkay Anaklı[SUP] 1 [/SUP], Günseli Orhun[SUP] 1 [/SUP], Gülçin Alay[SUP] 1 [/SUP], Figen Esen[SUP] 1 [/SUP]
Affiliations
Abstract
Hypercoagulopathy associated with the novel coronavirus disease (COVID-19) is the leading cause of acute respiratory distress syndrome (ARDS), multiple organ failure, and mortality. Extracorporeal membrane oxygenation (ECMO) has been used to manage patients with COVID 19-associated severe respiratory or cardiac failure. In this report, we aim to summarise our experience with deadly thrombotic complications during venovenous ECMO (vvECMO) treatment in 6 patients with COVID-19-associated ARDS between March 19, 2020 and April 20, 2020. Based on our experience with 6 COVID-19-associated ARDS patients on ECMO, we intend to raise awareness regarding thrombotic complications leading to mortality.
. 2021 Dec;49(6):480-483.
doi: 10.5152/TJAR.2020.1135.
Thrombotic Events Related to Extracorporeal Membrane Oxygenation in COVID-19-Associated Severe Acute Respiratory Distress Syndrome
Verda Tuna[SUP] 1 [/SUP], Perihan Ergin Özcan[SUP] 1 [/SUP], Emre Çeliksoy[SUP] 1 [/SUP], Özlem Polat[SUP] 1 [/SUP], İlkay Anaklı[SUP] 1 [/SUP], Günseli Orhun[SUP] 1 [/SUP], Gülçin Alay[SUP] 1 [/SUP], Figen Esen[SUP] 1 [/SUP]
Affiliations
- PMID: 35110028
- DOI: 10.5152/TJAR.2020.1135
Abstract
Hypercoagulopathy associated with the novel coronavirus disease (COVID-19) is the leading cause of acute respiratory distress syndrome (ARDS), multiple organ failure, and mortality. Extracorporeal membrane oxygenation (ECMO) has been used to manage patients with COVID 19-associated severe respiratory or cardiac failure. In this report, we aim to summarise our experience with deadly thrombotic complications during venovenous ECMO (vvECMO) treatment in 6 patients with COVID-19-associated ARDS between March 19, 2020 and April 20, 2020. Based on our experience with 6 COVID-19-associated ARDS patients on ECMO, we intend to raise awareness regarding thrombotic complications leading to mortality.